Combination Gerotherapeutic Interventions for Healthspan Improvement

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Healthspan Improvement, Aging, Longevity

In brief

This study is a 90-day interventional, randomized, controlled pilot trial exploring multi-modal gerotherapies and their impact on longevity-related outcomes. In this proof-of-concept phase, a small sample size of up to 30 subjects (10 subjects in each arm) will be randomized into one of the three arms: 1) Control, 2) Multi-therapy (B12, Naltrexone, Metformin, and NAD+), or 4) Comprehensive Therapy (Rapamycin, Naltrexone, Metformin, B12, NAD+, GSH, and Infinite Supplement).

Key facts

Study ID
NCT07475546
Run by
AgelessRx
People needed
30
Starts
2025-07-23
Expected to finish
2026-04-01
Last updated by the study team
2026-03-16

Who can join

Age: 60 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.